Literature DB >> 11125141

Identification of HE1 as the second gene of Niemann-Pick C disease.

S Naureckiene1, D E Sleat, H Lackland, A Fensom, M T Vanier, R Wattiaux, M Jadot, P Lobel.   

Abstract

Niemann-Pick type C2 disease (NP-C2) is a fatal hereditary disorder of unknown etiology characterized by defective egress of cholesterol from lysosomes. Here we show that the disease is caused by a deficiency in HE1, a ubiquitously expressed lysosomal protein identified previously as a cholesterol-binding protein. HE1 was undetectable in fibroblasts from NP-C2 patients but present in fibroblasts from unaffected controls and NP-C1 patients. Mutations in the HE1 gene, which maps to chromosome 14q24.3, were found in NP-C2 patients but not in controls. Treatment of NP-C2 fibroblasts with exogenous recombinant HE1 protein ameliorated lysosomal accumulation of low density lipoprotein-derived cholesterol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11125141     DOI: 10.1126/science.290.5500.2298

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  293 in total

1.  Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells.

Authors:  Heiko Runz; Jens Rietdorf; Inge Tomic; Marina de Bernard; Konrad Beyreuther; Rainer Pepperkok; Tobias Hartmann
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

2.  Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.

Authors:  G Millat; C Marçais; C Tomasetto; K Chikh; A H Fensom; K Harzer; D A Wenger; K Ohno; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-05-01       Impact factor: 11.025

3.  Characterization of a spontaneous novel mutation in the NPC2 gene in a cat affected by Niemann Pick type C disease.

Authors:  Stefania Zampieri; Ezio Bianchi; Carlo Cantile; Roberta Saleri; Bruno Bembi; Andrea Dardis
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

4.  Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse.

Authors:  Xin Yan; Jan Lukas; Martin Witt; Andreas Wree; Rayk Hübner; Moritz Frech; Rüdiger Köhling; Arndt Rolfs; Jiankai Luo
Journal:  Metab Brain Dis       Date:  2011-09-21       Impact factor: 3.584

5.  A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma.

Authors:  Xuntian Jiang; Rohini Sidhu; Forbes D Porter; Nicole M Yanjanin; Anneliese O Speak; Danielle Taylor te Vruchte; Frances M Platt; Hideji Fujiwara; David E Scherrer; Jessie Zhang; Dennis J Dietzen; Jean E Schaffer; Daniel S Ory
Journal:  J Lipid Res       Date:  2011-04-24       Impact factor: 5.922

6.  Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse.

Authors:  Benny Liu; Stephen D Turley; Dennis K Burns; Anna M Miller; Joyce J Repa; John M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

7.  Sphingolipid signalling mediates mitochondrial dysfunctions and reduced chronological lifespan in the yeast model of Niemann-Pick type C1.

Authors:  Rita Vilaça; Elísio Silva; André Nadais; Vítor Teixeira; Nabil Matmati; Joana Gaifem; Yusuf A Hannun; Maria Clara Sá Miranda; Vítor Costa
Journal:  Mol Microbiol       Date:  2013-12-12       Impact factor: 3.501

Review 8.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

9.  2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease.

Authors:  Jessica Davidson; Elizabeth Molitor; Samantha Moores; Sarah E Gale; Kanagaraj Subramanian; Xuntian Jiang; Rohini Sidhu; Pamela Kell; Jesse Zhang; Hideji Fujiwara; Cristin Davidson; Paul Helquist; Bruce J Melancon; Michael Grigalunas; Gang Liu; Farbod Salahi; Olaf Wiest; Xin Xu; Forbes D Porter; Nina H Pipalia; Dana L Cruz; Edward B Holson; Jean E Schaffer; Steven U Walkley; Frederick R Maxfield; Daniel S Ory
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-04-30       Impact factor: 4.698

Review 10.  Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.

Authors:  Tianxin Miao; Junqing Wang; Yun Zeng; Gang Liu; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2018-01-08       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.